VT News

George O'Leary

Ask VT AI
View News Summary
  • Foot Locker's earnings miss and lowered forecasts raise concerns about consumer demand and the company's turnaround efforts.
  • Eli Lilly's weight-loss drug Zepbound outperforms Novo Nordisk's Wegovy in a clinical trial, demonstrating superior efficacy in weight loss.
  • FIFA secures $1B deal with DAZN for 2025 Club World Cup, making it the 'most widely accessible club football tournament ever'.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Foot Locker's earnings miss and lowered forecasts raise concerns about consumer demand and the company's turnaround efforts.
  • Eli Lilly's weight-loss drug Zepbound outperforms Novo Nordisk's Wegovy in a clinical trial, demonstrating superior efficacy in weight loss.
  • FIFA secures $1B deal with DAZN for 2025 Club World Cup, making it the 'most widely accessible club football tournament ever'.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from George O'Leary

Top Topics

Trending in U.S.

World

Sport